Total Payments
$1.6M
2024 Payments
$163,448
Companies
2
Transactions
49
Payment Breakdown by Category
Royalty/License$1.6M (99.8%)
Consulting$2,907 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $1.6M | 48 | 99.8% |
| Consulting Fee | $2,907 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Helsinn Healthcare SA | $1.6M | 48 | $0 (2024) |
| Actelion Clinical Research, Inc. | $2,907 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $163,448 | 12 | Helsinn Healthcare SA ($163,448) |
| 2023 | $155,141 | 12 | Helsinn Healthcare SA ($155,141) |
| 2022 | $138,789 | 4 | Helsinn Healthcare SA ($138,789) |
| 2021 | $125,144 | 4 | Helsinn Healthcare SA ($125,144) |
| 2020 | $394,838 | 10 | Helsinn Healthcare SA ($394,838) |
| 2019 | $646,735 | 5 | Helsinn Healthcare SA ($646,735) |
| 2018 | $20,764 | 1 | Helsinn Healthcare SA ($20,764) |
| 2017 | $2,907 | 1 | Actelion Clinical Research, Inc. ($2,907) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $24,345.65 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $10,635.20 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $2,511.85 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2024 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $27,759.61 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2024 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $12,126.56 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2024 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $2,864.09 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2024 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $26,437.15 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2024 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $11,548.86 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2024 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $2,727.63 | General |
| Category: ONCOLOGY | ||||||
| 02/28/2024 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $27,591.82 | General |
| Category: ONCOLOGY | ||||||
| 02/28/2024 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $12,053.27 | General |
| Category: ONCOLOGY | ||||||
| 02/28/2024 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $2,846.77 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2023 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $26,839.44 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2023 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $11,724.59 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2023 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $2,769.15 | General |
| Category: ONCOLOGY | ||||||
| 08/10/2023 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $30,678.82 | General |
| Category: ONCOLOGY | ||||||
| 08/10/2023 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $13,401.79 | General |
| Category: ONCOLOGY | ||||||
| 08/10/2023 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $3,165.27 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2023 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $25,419.78 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2023 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $11,104.43 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2023 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $2,622.68 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2023 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $17,802.05 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2023 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $7,776.68 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2023 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $1,836.72 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2022 | Helsinn Healthcare SA | VALCHLOR (Drug) | Royalty or License | Cash or cash equivalent | $34,988.62 | General |
| Category: ONCOLOGY | ||||||
About Timothy Henkel, MD, PHD
Timothy Henkel, MD, PHD is a Infectious Disease healthcare provider based in Hilton Head Island, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2009. The National Provider Identifier (NPI) number assigned to this provider is 1467789909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Timothy Henkel, MD, PHD has received a total of $1.6M in payments from pharmaceutical and medical device companies, with $163,448 received in 2024. These payments were reported across 49 transactions from 2 companies. The most common payment nature is "Royalty or License" ($1.6M).
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease
- Location Hilton Head Island, SC
- Active Since 11/04/2009
- Last Updated 03/20/2024
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467789909
Products in Payments
- VALCHLOR (Drug) $1.6M
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.